Diabetes Mellitus Clinical Trial
Official title:
Diabetes Screening and Monitoring Using Tongue Images and Self-reported Symptoms: a Machine Learning Approach
Study Background: Diabetes mellitus (DM) is a major non-communicable disease. Diagnosis and self-management of DM is important. Currently, detection of diabetes requires blood tests, which is costly and inconvenient, especially for elderlies.Tongue diagnosis has been used in Chinese medicine as a routine diagnostic method, and it has recently been studied for detection of DM and diabetic retinopathy (DR). We have developed a method for taking tongue images using smartphone, which can reveal more detailed features than conventional clinical tongue inspection. There are many limitations of the preliminary study. Therefore, it is our plan in this study to address these specific limitations with the following objectives. The results of this study will enable us to develop a practical App for diabetes screening and monitoring. Study Objective The aim of the study is to develop an algorithm for diabetes screening, with the following objectives: 1. . To determine the sensitivity and specificity of tongue images taken with smartphone in predicting abnormal HbA1c (≥6.5%); 2. To determine tongue image features responsible for the classification of normal and abnormal levels of HbA1c (≥6.5%); 3. To determine the sensitivity and specificity of tongues image in predicting four different levels of HbA1c: <6% (normal), 6-6.4% (prediabetes), 6.5-8.9% (diabetes) and ≥ 9% (diabetes with high HbA1c); 4. To determine the sensitivity and specificity of combining image analysis results with the results from a TCM symptom questionnaire in predicting the four levels of HbA1c. Hypothesis: Our working hypothesis is that different tongue coating features may be associated with different stages of diabetes, as indicated by different levels of HbA1c;and different combination of symptoms from a TCM point of view may also be associated with different levels of HbA1c. Thus, combining tongue image with TCM symptoms may allow a machine learning model to build an algorithm for HbA1c prediction with reasonable accuracy. Inclusion criteria: The inclusion criteria is adult subjects with HbA1c test results from a laboratory that meets the ISO 15189 standard, such as those laboratories used by the Hospital Authority of Hong Kong. Exclusion criteria: Subjects who are unable to give consent, unable to answer the questionnaire or to cooperate in tongue image collection will be excluded. We will not include subject who are unable to understand written Chinese or English. Study design: This is a cross-sectional design looking at the relationship between tongue image pattern and HbA1c reading. Age, gender, weight, height , duration of diabetes, family history of diabetes and any comorbid disease will be recorded. The level of hemoglobin and blood lipid profile will also be recorded if the information is available. Any acute repertory or digestive illness, as well as smoking habits will also be noted. An electronic questionnaire (using Qualtrics survey software) based on published TCM symptoms of diabetes and the abovementioned information will be used for data collection. Data processing and analysis 1. Tongue segmentation The images containing the tongue and its surrounding area will be processed for segmentation of the tongue area. This segmentation is carried out by a computer algorithm developed in-house by machine learning. 2. Machine learning Two approaches will be used in machine learning. In the first approach, we will first perform image classification of either normal or abnormal HbA1c and generate the probabilities for the classification using convolutional neural networks (CNNs) (Anwar et al., 2016; Ødegaard et al., 2016). Then we will try to classify the images into four different classes according to their HbA1c level: <6% (normal), 6-6.4% (prediabetes), 6.5-8.9% (diabetes) and ≥ 9% (diabetes with high HbA1c). Primary Outcome: Tongue image features: We will extract tongue image features and perform image classification of either normal or abnormal HbA1c and generate the probabilities for the classification using convolutional neural networks (CNNs). Then we will try to classify the images into four different classes according to their HbA1c level: <6% (normal), 6-6.4% (prediabetes), 6.5-8.9% (diabetes) and ≥ 9% (diabetes with high HbA1c). Secondary Outcome: Symptom patterns: Questionnaire data will be combined with image data for regression analysis
Status | Recruiting |
Enrollment | 4000 |
Est. completion date | June 30, 2024 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: Adult subjects With HbA1c test results from a laboratory meeting the ISO 15189 standard within two weeks before or after the tongue images and questionnaire collection. Exclusion Criteria: Unable to give consent Unable to answer the questionnaire or to cooperate in tongue image collection Unable to understand written Chinese or English. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Queen Elizabeth Hospital | Kowloon | |
Hong Kong | School of Chinese Medicine Building | Kowloon Tong | Kowloon |
Lead Sponsor | Collaborator |
---|---|
Hong Kong Baptist University | Guangdong Provincial Hospital of Traditional Chinese Medicine, Health and Medical Research Fund, The Queen Elizabeth Hospital |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tongue image features | We will extract tongue image features and perform image classification of either normal or abnormal HbA1c and generate the probabilities for the classification using convolutional neural networks (CNNs). Then we will try to classify the images into four different classes according to their HbA1c level: <6% (normal), 6-6.4% (prediabetes), 6.5-8.9% (diabetes) and = 9% (diabetes with high HbA1c). Then find out whether there is any difference among touge images in different groups. | Through study completion, an average of 1year | |
Secondary | Symptom patterns | Questionnaire data will be combined with image data for regression analysis | Through study completion, an average of 1year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |